Strides Pharma Science Dividende

Zukünftiges Wachstum Kriterienprüfungen 1/6

Strides Pharma Science ist ein dividendenzahlendes Unternehmen mit einer aktuellen Rendite von 0.25%.

Wichtige Informationen

0.3%

Dividendenausschüttung

-18%

Ausschüttungsquote

Durchschnittlicher Branchenertrag0.8%
Nächster Dividendenzahlungsterminn/a
Ex-Dividendendatumn/a
Dividende pro Aktien/a
Gewinn pro Aktie-₹13.58
Erwartete Dividendenrendite in 3 Jahren0.4%

Aktuelle Dividendenentwicklung

Strides Pharma Science (NSE:STAR) Has Announced That It Will Be Increasing Its Dividend To ₹2.50

Jul 28
Strides Pharma Science (NSE:STAR) Has Announced That It Will Be Increasing Its Dividend To ₹2.50

Recent updates

Investors Still Waiting For A Pull Back In Strides Pharma Science Limited (NSE:STAR)

Apr 04
Investors Still Waiting For A Pull Back In Strides Pharma Science Limited (NSE:STAR)

Does Strides Pharma Science (NSE:STAR) Have A Healthy Balance Sheet?

Feb 29
Does Strides Pharma Science (NSE:STAR) Have A Healthy Balance Sheet?

Strides Pharma Science Limited's (NSE:STAR) Shares Leap 31% Yet They're Still Not Telling The Full Story

Dec 23
Strides Pharma Science Limited's (NSE:STAR) Shares Leap 31% Yet They're Still Not Telling The Full Story

We Think Strides Pharma Science (NSE:STAR) Is Taking Some Risk With Its Debt

Sep 26
We Think Strides Pharma Science (NSE:STAR) Is Taking Some Risk With Its Debt

Does Strides Pharma Science (NSE:STAR) Have A Healthy Balance Sheet?

Jun 08
Does Strides Pharma Science (NSE:STAR) Have A Healthy Balance Sheet?

Strides Pharma Science Limited (NSE:STAR) Just Reported First-Quarter Earnings And Analysts Are Lifting Their Estimates

Aug 02
Strides Pharma Science Limited (NSE:STAR) Just Reported First-Quarter Earnings And Analysts Are Lifting Their Estimates

Is Strides Pharma Science (NSE:STAR) A Risky Investment?

Jun 25
Is Strides Pharma Science (NSE:STAR) A Risky Investment?

Does Strides Pharma Science (NSE:STAR) Have A Healthy Balance Sheet?

Dec 21
Does Strides Pharma Science (NSE:STAR) Have A Healthy Balance Sheet?

Strides Pharma Science (NSE:STAR) Has Announced That It Will Be Increasing Its Dividend To ₹2.50

Jul 28
Strides Pharma Science (NSE:STAR) Has Announced That It Will Be Increasing Its Dividend To ₹2.50

Estimating The Fair Value Of Strides Pharma Science Limited (NSE:STAR)

Apr 13
Estimating The Fair Value Of Strides Pharma Science Limited (NSE:STAR)

Should Strides Pharma Science Limited (NSE:STAR) Be Part Of Your Dividend Portfolio?

Mar 04
Should Strides Pharma Science Limited (NSE:STAR) Be Part Of Your Dividend Portfolio?

These 4 Measures Indicate That Strides Pharma Science (NSE:STAR) Is Using Debt Extensively

Feb 15
These 4 Measures Indicate That Strides Pharma Science (NSE:STAR) Is Using Debt Extensively

Can Mixed Fundamentals Have A Negative Impact on Strides Pharma Science Limited (NSE:STAR) Current Share Price Momentum?

Jan 26
Can Mixed Fundamentals Have A Negative Impact on Strides Pharma Science Limited (NSE:STAR) Current Share Price Momentum?

The Strides Pharma Science (NSE:STAR) Share Price Is Up 140% And Shareholders Are Boasting About It

Jan 11
The Strides Pharma Science (NSE:STAR) Share Price Is Up 140% And Shareholders Are Boasting About It

Who Has Been Selling Strides Pharma Science Limited (NSE:STAR) Shares?

Dec 28
Who Has Been Selling Strides Pharma Science Limited (NSE:STAR) Shares?

Are Strides Pharma Science's (NSE:STAR) Statutory Earnings A Good Guide To Its Underlying Profitability?

Dec 10
Are Strides Pharma Science's (NSE:STAR) Statutory Earnings A Good Guide To Its Underlying Profitability?

Could The Strides Pharma Science Limited (NSE:STAR) Ownership Structure Tell Us Something Useful?

Nov 25
Could The Strides Pharma Science Limited (NSE:STAR) Ownership Structure Tell Us Something Useful?

Stabilität und Wachstum des Zahlungsverkehrs

Rufe Dividendendaten ab

Stabile Dividende: STARDie Dividendenzahlungen des Unternehmens waren in den vergangenen 10 Jahren volatil.

Wachsende Dividende: STARDie Dividendenzahlungen des Unternehmens sind in den letzten 10 Jahren zurückgegangen.


Dividendenrendite im Vergleich zum Markt

Strides Pharma Science Dividendenrendite im Vergleich zum Markt
Wie sieht die Dividendenrendite von STAR im Vergleich zum Markt aus?
SegmentDividendenrendite
Unternehmen (STAR)0.3%
Untere 25 % des Marktes (IN)0.3%
Markt Top 25 % (IN)1.1%
Branchendurchschnitt (Pharmaceuticals)0.8%
Analystenprognose in 3 Jahren (STAR)0.4%

Bemerkenswerte Dividende: STARDie Dividende des Unternehmens (0.29%) ist im Vergleich zu den unteren 25 % der Dividendenzahler auf dem Markt Indian (0.31%) nicht bemerkenswert.

Hohe Dividende: STARDie Dividende des Unternehmens (0.25%) ist im Vergleich zu den besten 25% der Dividendenzahler auf dem Markt Indian (1.13%) niedrig.


Gewinnausschüttung an die Aktionäre

Abdeckung der Erträge: STAR zahlt eine Dividende, aber das Unternehmen ist unrentabel.


Barausschüttung an die Aktionäre

Cashflow-Deckung: Mit seiner niedrigen Ausschüttungsquote (3.9%) sind die Dividendenzahlungen von STAR vollständig durch den Cashflow gedeckt.


Entdecken Sie dividendenstarke Unternehmen